Clinical trial

Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

NCT00734045

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-02-01

PhaseN/A

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2008-12-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Congestive Heart Failure (CHF)unresolved

Interventions

Sponsors & collaborators

Nanogen, Inc.lead sponsor

Mapped research locations

San FranciscoCalifornia, United States1 San DiegoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00734045 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.